IDALOPIRDINE, A 5-HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-MODERATE ALZHEIMER’S DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM
Atri, Alireza, Frölich, Lutz, Ballard, Clive, Tariot, Pierre, Molinuevo, José Luis, Boneva, Neli, Windfeld, Kristian, Cummings, Jeffrey L.Volume:
13
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2017.08.007
Date:
July, 2017
File:
PDF, 234 KB
english, 2017